EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

FibroScan‐AST score for diagnosing fibrotic MASH: A systematic review and meta‐analysis of diagnostic test accuracy studies

Konstantinos Malandris iD, Dimitrios Arampidis, Maria Mainou, Nikolaos Papadopoulos, Thomas Karagiannis iD, Tarek Nayfeh iD, Aris Liakos iD, Emmanouil Sinakos, Apostolos Tsapas iD, Eleni Bekiari iD

Journal of Gastroenterology and Hepatology · 2024-12 · 39 (12) · 2582-2591

DOI: 10.1111/jgh.16770 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 12.10.2024. Verfasst von Konstantinos Malandris und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Elasticity Imaging Techniques, Liver Cirrhosis, Aspartate Aminotransferases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Following the approval of the first agent for the management of metabolic dysfunction‐associated steatohepatitis (MASH), identification of patients with fibrotic MASH (MASH with NAS ≥ 4 and fibrosis stage ≥ 2) is crucial. We assessed the performance of FibroScan‐aspartate aminotransferase (AST) score (FAST) for ruling in/out fibrotic MASH.

Methods

We searched Medline, Cochrane Library, Web of Science, Scopus, and gray literature sources up to January 11, 2024. Studies were eligible if they assessed the accuracy of FAST score for the detection of fibrotic MASH using biopsy as the reference standard at previously reported thresholds (FAST ≥ 0.67 for ruling‐in and ≤ 0.35 for ruling‐out fibrotic MASH). We calculated pooled sensitivity and specificity estimates for FAST thresholds alongside 95% confidence intervals following bivariate random‐ effects models. We assessed the certainty of evidence using the Grading of Recommendations Assessment, Development and Evaluation framework.

Results

We included 16 studies with 8838 participants. A FAST score ≥ 0.67 yielded a pooled specificity of 0.87 (0.82–0.90) while a FAST score ≤ 0.35 yielded a summary sensitivity of 0.88 (0.83–0.91). At a prevalence of 30%, the positive predictive value for ruling‐in fibrotic MASH was 60% while the negative predictive value for ruling‐out the target condition was 91%. AST levels, cirrhosis prevalence, and number of pathologists reviewing biopsies were sources of heterogeneity among studies. The certainty of evidence was low to very low.

Conclusions

FAST score can be used as a triage test for ruling out fibrotic MASH. Nevertheless, its low positive predictive value necessitates sequential testing for ruling‐in fibrotic MASH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Elasticity Imaging TechniquesLiver CirrhosisAspartate AminotransferasesHumansSensitivity and SpecificityFatty Liver

Stichwörter der Autor:innen

Diagnostic accuracyFAST scoreMASHMeta‐analysisSystematic review

Substanzen

Aspartate Aminotransferases

Autor:innen und Institutionen

  • Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • School of Medicine, Faculty of Health Science, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Evidence-based Practice Center, Mayo Clinic, Rochester, Minnesota, USA.
  • Fourth Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Harris Manchester College, University of Oxford, Oxford, UK.

ORCID-Profile: Konstantinos Malandris, Thomas Karagiannis, Tarek Nayfeh, Aris Liakos, Apostolos Tsapas, Eleni Bekiari

Zitieren

APA

Malandris, K., Arampidis, D., Mainou, M., Papadopoulos, N., Karagiannis, T., Nayfeh, T., Liakos, A., Sinakos, E., Tsapas, A., & Bekiari, E. (2024). FibroScan‐AST score for diagnosing fibrotic MASH: A systematic review and meta‐analysis of diagnostic test accuracy studies. Journal of Gastroenterology and Hepatology, 39(12), 2582-2591. https://doi.org/10.1111/jgh.16770

Vancouver

Malandris K, Arampidis D, Mainou M, Papadopoulos N, Karagiannis T, Nayfeh T, et al. FibroScan‐AST score for diagnosing fibrotic MASH: A systematic review and meta‐analysis of diagnostic test accuracy studies. Journal of Gastroenterology and Hepatology. 2024;39(12):2582-2591. doi:10.1111/jgh.16770

BibTeX
@article{Malandris2024,
  author = {Malandris, Konstantinos and Arampidis, Dimitrios and Mainou, Maria and Papadopoulos, Nikolaos and Karagiannis, Thomas and Nayfeh, Tarek and Liakos, Aris and Sinakos, Emmanouil and Tsapas, Apostolos and Bekiari, Eleni},
  title = {FibroScan‐AST score for diagnosing fibrotic MASH: A systematic review and meta‐analysis of diagnostic test accuracy studies},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2024},
  volume = {39},
  number = {12},
  pages = {2582--2591},
  doi = {10.1111/jgh.16770}
}
Kostenlos starten →